Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations.

Trautwein EA, Du Y, Meynen E, Yan X, Wen Y, Wang H, Molhuizen HO.

Eur J Nutr. 2010 Feb;49(1):27-35. doi: 10.1007/s00394-009-0045-7. Epub 2009 Jul 29.

PMID:
19639377
2.

Black tea consumption dose-dependently improves flow-mediated dilation in healthy males.

Grassi D, Mulder TP, Draijer R, Desideri G, Molhuizen HO, Ferri C.

J Hypertens. 2009 Apr;27(4):774-81. doi: 10.1097/HJH.0b013e328326066c.

PMID:
19516176
3.

Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles.

Vermeer MA, Mulder TP, Molhuizen HO.

J Agric Food Chem. 2008 Dec 24;56(24):12031-6. doi: 10.1021/jf8022035.

PMID:
19049290
4.

Plant sterol-enriched milk tea decreases blood cholesterol concentrations in Chinese adults: a randomised controlled trial.

Li NY, Li K, Qi Z, Demonty I, Gordon M, Francis L, Molhuizen HO, Neal BC.

Br J Nutr. 2007 Nov;98(5):978-83. Epub 2007 Jul 9.

PMID:
17617940
5.

Cholesterol ester transfer protein (CETP) Taq1B polymorphism influences the effect of a standardized cardiac rehabilitation program on lipid risk markers.

Ayyobi AF, Hill JS, Molhuizen HO, Lear SA.

Atherosclerosis. 2005 Aug;181(2):363-9. Epub 2005 Mar 17.

PMID:
16039291
6.

Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.

Levels JH, Marquart JA, Abraham PR, van den Ende AE, Molhuizen HO, van Deventer SJ, Meijers JC.

Infect Immun. 2005 Apr;73(4):2321-6.

7.

The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.

Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.

Am Heart J. 2003 Dec;146(6):1007-14.

PMID:
14660992
8.

A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.

Nanjee MN, Stocks J, Cooke CJ, Molhuizen HO, Marcovina S, Crook D, Kastelein JP, Miller NE.

Atherosclerosis. 2003 Sep;170(1):105-13.

PMID:
12957688
9.

Transcriptional regulation of the elafin gene in human keratinocytes.

Pol A, Pfundt R, Zeeuwen P, Molhuizen H, Schalkwijk J.

J Invest Dermatol. 2003 Feb;120(2):301-7.

10.

Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration.

Klerkx AH, Tanck MW, Kastelein JJ, Molhuizen HO, Jukema JW, Zwinderman AH, Kuivenhoven JA.

Hum Mol Genet. 2003 Jan 15;12(2):111-23.

PMID:
12499392
11.

ATP binding cassette G5 C1950G polymorphism may affect blood cholesterol concentrations in humans.

Weggemans RM, Zock PL, Tai ES, Ordovas JM, Molhuizen HO, Katan MB.

Clin Genet. 2002 Sep;62(3):226-9.

PMID:
12220438
12.

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.

van der Valk M, Kastelein JJ, Murphy RL, van Leth F, Katlama C, Horban A, Glesby M, Behrens G, Clotet B, Stellato RK, Molhuizen HO, Reiss P; Atlantic Study Team.

AIDS. 2001 Dec 7;15(18):2407-14.

PMID:
11740191
13.

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.

Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest J Jr, Kastelein JJ, Hayden MR.

Circulation. 2001 Mar 6;103(9):1198-205.

PMID:
11238261
14.

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Clee SM, Kastelein JJ, van Dam M, Marcil M, Roomp K, Zwarts KY, Collins JA, Roelants R, Tamasawa N, Stulc T, Suda T, Ceska R, Boucher B, Rondeau C, DeSouich C, Brooks-Wilson A, Molhuizen HO, Frohlich J, Genest J Jr, Hayden MR.

J Clin Invest. 2000 Nov;106(10):1263-70.

15.

Biochemical and compositional analyses of recombinant lecithin:cholesterol acyltransferase (LCAT) obtained from a hepatic source.

Ayyobi AF, Lacko AG, Murray K, Nair M, Li M, Molhuizen HO, Pritchard PH.

Biochim Biophys Acta. 2000 Feb 24;1484(1):1-13.

PMID:
10685026
16.

Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.

Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, Collins JA, van Dam M, Molhuizen HO, Loubster O, Ouellette BF, Sensen CW, Fichter K, Mott S, Denis M, Boucher B, Pimstone S, Genest J Jr, Kastelein JJ, Hayden MR.

Lancet. 1999 Oct 16;354(9187):1341-6.

PMID:
10533863
17.

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J Jr, Hayden MR.

Nat Genet. 1999 Aug;22(4):336-45.

PMID:
10431236
18.

Rapid detection and simultaneous strain differentiation of Mycobacterium tuberculosis complex bacteria by spoligotyping.

Molhuizen HO, Bunschoten AE, Schouls LM, van Embden JD.

Methods Mol Biol. 1998;101:381-94. No abstract available.

PMID:
9921492
19.

Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy.

Rust S, Walter M, Funke H, von Eckardstein A, Cullen P, Kroes HY, Hordijk R, Geisel J, Kastelein J, Molhuizen HO, Schreiner M, Mischke A, Hahmann HW, Assmann G.

Nat Genet. 1998 Sep;20(1):96-8. Erratum in: Nat Genet 1998 Nov;20(3):312.

PMID:
9731541
20.

SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis.

Kuijpers AL, Pfundt R, Zeeuwen PL, Molhuizen HO, Mariman EC, van de Kerkhof PC, Schalkwijk J.

Clin Genet. 1998 Jul;54(1):96-101.

PMID:
9727750
21.

Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J.

J Clin Microbiol. 1997 Apr;35(4):907-14.

22.

Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI.

Molhuizen HO, Schalkwijk J.

Biol Chem Hoppe Seyler. 1995 Jan;376(1):1-7. Review.

PMID:
7612183
23.

SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.

Alkemade JA, Molhuizen HO, Ponec M, Kempenaar JA, Zeeuwen PL, de Jongh GJ, van Vlijmen-Willems IM, van Erp PE, van de Kerkhof PC, Schalkwijk J.

J Cell Sci. 1994 Aug;107 ( Pt 8):2335-42.

24.

Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13.

Molhuizen HO, Zeeuwen PL, Olde Weghuis D, Geurts van Kessel A, Schalkwijk J.

Cytogenet Cell Genet. 1994;66(2):129-31.

PMID:
8287685
25.

Differential expression of SKALP/Elafin in human epidermal tumors.

Alkemade HA, Molhuizen HO, van Vlijmen-Willems IM, van Haelst UJ, Schalkwijk J.

Am J Pathol. 1993 Dec;143(6):1679-87.

26.

SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking.

Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, Schalkwijk J.

J Biol Chem. 1993 Jun 5;268(16):12028-32.

27.

Cloning and sequence analysis of brain cDNA encoding a Xenopus D2 dopamine receptor.

Martens GJ, Molhuizen HO, Gröneveld D, Roubos EW.

FEBS Lett. 1991 Apr 9;281(1-2):85-9.

Supplemental Content

Loading ...
Support Center